• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$9.54
+0 (0.00%)
Get New SeaSpine Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SPNE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SPNE

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for SeaSpine in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $9.54.

This chart shows the closing price for SPNE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in SeaSpine. This rating has held steady since November 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/2/2022Truist FinancialDowngradeBuy ➝ Hold$12.00 ➝ $6.75
8/3/2022Piper SandlerLower TargetOverweight$21.00 ➝ $12.00
7/20/2022Truist FinancialLower TargetBuy$20.00 ➝ $12.00
6/30/2022BTIG ResearchLower Target$23.00 ➝ $19.00
4/22/2022Cantor FitzgeraldLower TargetOverweight$27.00 ➝ $21.00
4/12/2022Cantor FitzgeraldReiterated RatingOverweight
3/14/2022Stifel NicolausLower TargetBuy$18.00 ➝ $16.00
3/14/2022Piper SandlerLower TargetOverweight$28.00 ➝ $21.00
12/21/2021Truist FinancialLower TargetBuy$25.00 ➝ $20.00
10/28/2021Loop CapitalInitiated CoverageBuy$100.00
9/27/2021BTIG ResearchLower TargetBuy$28.00 ➝ $23.00
4/14/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$24.00
4/8/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$19.00 ➝ $24.00
4/6/2021BTIG ResearchBoost TargetBuy$25.00 ➝ $28.00
1/29/2021Piper SandlerBoost TargetOverweight$18.00 ➝ $22.00
10/19/2020Stifel NicolausInitiated CoverageBuy$22.00
8/4/2020BTIG ResearchReiterated RatingBuy$16.00
6/15/2020Cantor FitzgeraldInitiated CoverageBuy$18.00
6/8/2020Cantor FitzgeraldReiterated RatingOverweight
4/19/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight
4/7/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$10.00
4/2/2020SunTrust BanksInitiated CoverageBuy$15.00
(Data available from 12/26/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
SeaSpine logo
As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.
Read More

Today's Range

Now: $9.54
Low: $8.43
High: $9.67

50 Day Range

MA: $8.53
Low: $7.03
High: $9.54

52 Week Range

Now: $9.54
Low: $5.48
High: $14.23

Volume

1,161,199 shs

Average Volume

822,700 shs

Market Capitalization

$354.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Frequently Asked Questions

What sell-side analysts currently cover shares of SeaSpine?

The following sell-side analysts have issued research reports on SeaSpine in the last year: StockNews.com.
View the latest analyst ratings for SPNE.

What is the current price target for SeaSpine?

0 Wall Street analysts have set twelve-month price targets for SeaSpine in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for SeaSpine in the next year.
View the latest price targets for SPNE.

What is the current consensus analyst rating for SeaSpine?

SeaSpine currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SPNE.

What other companies compete with SeaSpine?

Other companies that are similar to SeaSpine include MiMedx Group, Alphatec, Embecta, Artivion and Pulse Biosciences. Learn More about companies similar to SeaSpine.

How do I contact SeaSpine's investor relations team?

SeaSpine's physical mailing address is 5770 ARMADA DRIVE, CARLSBAD CA, 92008. The medical equipment provider's listed phone number is (760) 727-8399 and its investor relations email address is [email protected]. The official website for SeaSpine is www.seaspine.com. Learn More about contacing SeaSpine investor relations.